Results 221 to 230 of about 73,119 (252)
Some of the next articles are maybe not open access.
Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment
International Journal of Molecular Sciences, 2023Sanaa K Bardaweel
exaly
Matrix metalloproteinase inhibitors.
IDrugs : the investigational drugs journal, 2010The Division of Medicinal Chemistry offered a number of sub-sessions including this one on matrix metalloproteinase (MMP) inhibitors. The overexpression of matrix metalloproteinases has been associated with cancer malignancy, arthritis and several immune system-related infectious diseases such as sepsis.
openaire +1 more source
Matrix metalloproteinases and their inhibitors.
Anticancer research, 1999Degradation of the extracellular matrix around tumour cells is an essential step in the process of tumour invasion and metastasis. The family of structurally related metalloproteinases (MMPs) and their inhibitors, the tissue inhibitors of metalloproteinases (TIMP), play an important role in matrix degradation by tumour cells. In this paper MMP and TIMP
openaire +1 more source
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Chemical Reviews, 1999Mark Whittaker +2 more
exaly
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview
European Journal of Medicinal Chemistry, 2020, Suvankar Banerjee, Sk Abdul Amin
exaly
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Nature Reviews Drug Discovery, 2007Jialiang Hu +2 more
exaly